Malignant Melanoma Complicated with Cataract and Secondary Glaucoma: A Case Report

Overview

Journal Oncol Lett

Specialty Oncology

Date 2024 Sep 13

PMID 39268160

Authors

Yu Wang

Qinqin Sun

Zhijian Li

Fei Leng

Xuelian Han

Qiqi Su

Sheng Su

Affiliations

Soon will be listed here.

Abstract

Uveal melanoma is the most common intraocular malignant tumor in adults. For patients presenting with cataracts and glaucoma, it is recommended to assess whether an intraocular lesion is present as the primary cause. The present study describes the case of a 52-year-old man with primary intraocular malignant melanoma. The patient experienced painless vision loss in the right eye for 1 year, with recent onset of eye swelling and pain in the week prior to seeking medical attention. A slit-lamp examination revealed a shallow anterior chamber in the right eye, a visibly opaque lens and a faint reflection of the tumor surface in the vitreous humor. In addition, the intraocular pressure of this eye was >60 mmHg. Magnetic resonance imaging revealed a large tumor behind the lens measuring 16×18×14 mm. Pathological examination confirmed the diagnosis of malignant melanoma. No BRCA-associated protein-1 somatic mutation was detected, whereas germline mutations of MutL protein homolog 1, RAD54 like, and SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 were identified. Extensive systemic examination excluded the possibility that the tumors originated from another part of the body. The present case report highlights the crucial role of slit-lamp examination in the detection of ocular tumors. It is advocated that for patients presenting with cataracts, attention should be paid to the possibility of intraocular tumors. Meticulous slit-lamp microscopy may reveal a reflection of the surface of a malignant melanoma, preventing misdiagnosis.

References

Liu Y, Li Y, Wei W, Xu X, Jonas J . Clinical Characteristics of 582 Patients with Uveal Melanoma in China. PLoS One. 2015; 10(12):e0144562. PMC: 4672905. DOI: 10.1371/journal.pone.0144562. View

Ryu B, Kim D, DeLuca A, Alani R . Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS One. 2007; 2(7):e594. PMC: 1895889. DOI: 10.1371/journal.pone.0000594. View

de Vries T, Fourkour A, Wobbes T, Verkroost G, Ruiter D, van Muijen G . Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res. 1997; 57(15):3223-9. View

Adam G, Brab M, Bohndorf K, Gunther R . Gadolinium-DTPA-enhanced MRI of intraocular tumors. Magn Reson Imaging. 1990; 8(6):683-9. DOI: 10.1016/0730-725x(90)90002-j. View

Latham A, Srinivasan P, Kemel Y, Shia J, Bandlamudi C, Mandelker D . Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer. J Clin Oncol. 2018; 37(4):286-295. PMC: 6553803. DOI: 10.1200/JCO.18.00283. View

Field M, Durante M, Anbunathan H, Cai L, Decatur C, Bowcock A . Punctuated evolution of canonical genomic aberrations in uveal melanoma. Nat Commun. 2018; 9(1):116. PMC: 5760704. DOI: 10.1038/s41467-017-02428-w. View

Augsburger J, Gamel J, Lauritzen K, BRADY L . Cobalt-60 plaque radiotherapy vs enucleation for posterior uveal melanoma. Am J Ophthalmol. 1990; 109(5):585-92. DOI: 10.1016/s0002-9394(14)70691-9. View

Xue Y, Meehan B, Fu Z, Wang X, Fiset P, Rieker R . SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer. Nat Commun. 2019; 10(1):557. PMC: 6362083. DOI: 10.1038/s41467-019-08380-1. View

JENSEN O . Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943--1952. Acta Ophthalmol (Copenh). 1982; 60(2):161-82. DOI: 10.1111/j.1755-3768.1982.tb08371.x. View

10.

McLaughlin C, Wu X, Jemal A, Martin H, Roche L, Chen V . Incidence of noncutaneous melanomas in the U.S. Cancer. 2005; 103(5):1000-7. DOI: 10.1002/cncr.20866. View

11.

Diener-West M, Hawkins B, Markowitz J, Schachat A . A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol. 1992; 110(2):245-50. DOI: 10.1001/archopht.1992.01080140101036. View

12.

Steckler A, Francis J, Shoushtari A, Abramson D, Barker C . Uveal melanoma metastatic at initial diagnosis: a case series. Melanoma Res. 2022; 32(2):120-123. PMC: 8901542. DOI: 10.1097/CMR.0000000000000807. View

13.

Figueiredo C, Kalirai H, Sacco J, Azevedo R, Duckworth A, Slupsky J . Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development. J Pathol. 2020; 250(4):420-439. PMC: 7216965. DOI: 10.1002/path.5384. View

14.

Diener-West M, Reynolds S, Agugliaro D, Caldwell R, Cumming K, Earle J . Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol. 2005; 123(12):1639-43. DOI: 10.1001/archopht.123.12.1639. View

15.

Guerrero-Martinez J, Reyes J . High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer. Sci Rep. 2018; 8(1):2043. PMC: 5794756. DOI: 10.1038/s41598-018-20217-3. View

16.

Neupane R, Gaudana R, Boddu S . Imaging Techniques in the Diagnosis and Management of Ocular Tumors: Prospects and Challenges. AAPS J. 2018; 20(6):97. DOI: 10.1208/s12248-018-0259-9. View

17.

Augsburger J, Gamel J, Sardi V, Greenberg R, Shields J, BRADY L . Enucleation vs cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body. Arch Ophthalmol. 1986; 104(5):655-61. DOI: 10.1001/archopht.1986.01050170045019. View

18.

Karlsson J, Nilsson L, Mitra S, Alsen S, Shelke G, Sah V . Molecular profiling of driver events in metastatic uveal melanoma. Nat Commun. 2020; 11(1):1894. PMC: 7171146. DOI: 10.1038/s41467-020-15606-0. View

19.

McLean I, FOSTER W, ZIMMERMAN L, Gamel J . Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol. 1983; 96(4):502-9. DOI: 10.1016/s0002-9394(14)77914-0. View

20.

Shields C, Furuta M, Thangappan A, Nagori S, Mashayekhi A, Lally D . Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol. 2009; 127(8):989-98. DOI: 10.1001/archophthalmol.2009.208. View